ConductScience.org, home

Paper39282196

The Impact of Fosfomycin on Gram Negative Infections: A Comprehensive Review.

Dubey S and 2 others. Indian J Microbiol, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. The Impact of Fosfomycin on Gram Negative Infections: A Comprehensive Review. Papers, record 39282196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39282196

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Impact of Fosfomycin on Gram Negative Infections: A Comprehensive Review.
PubMed
Journal
Indian J Microbiol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.31, provisional
iCite
Revised in PubMed
2025-09-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dubey SSandeepikahttps://orcid.org/0009-0002-2191-0735
2Siddiqui AHAreena Hoda
3Sharma MMeenakshi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References120

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114677948Mechanistic diversity of fosfomycin resistance in pathogenic microorganisms.J Am Chem Soc2003https://conductscience.org/library/papers/14677948PubMed
224379684Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy.Infect Drug Resist2013https://conductscience.org/library/papers/24379684PubMed
323295934Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing Escherichia coli in a foreign-body infection model.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23295934PubMed
424315790In vitro and intracellular activities of fosfomycin against clinical strains of Listeria monocytogenes.Int J Antimicrob Agents2014https://conductscience.org/library/papers/24315790PubMed
54605290The mechanism of action of fosfomycin (phosphonomycin).Ann N Y Acad Sci1974https://conductscience.org/library/papers/4605290PubMed
62037534Effect of non-beta-lactam antibiotics on penicillin-binding protein synthesis of Enterococcus hirae ATCC 9790.J Antimicrob Chemother1991https://conductscience.org/library/papers/2037534PubMed
723546462[Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].Rev Esp Quimioter2013https://conductscience.org/library/papers/23546462PubMed
819915879Fosfomycin: an old, new friend?Eur J Clin Microbiol Infect Dis2010https://conductscience.org/library/papers/19915879PubMed
98682732Fosfomycin monophosphate and fosfomycin diphosphate, two inactivated fosfomycin derivatives formed by gene products of fomA and fomB from a fosfomycin producing organism Streptomyces wedmorensis.J Antibiot (Tokyo)1996https://conductscience.org/library/papers/8682732PubMed
1027956267Intravenous fosfomycin-back to the future. Systematic review and meta-analysis of the clinical literature.Clin Microbiol Infect2017https://conductscience.org/library/papers/27956267PubMed
1125048851Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.Clin Infect Dis2014https://conductscience.org/library/papers/25048851PubMed
1227261267Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli.J Antimicrob Chemother2016https://conductscience.org/library/papers/27261267PubMed
131963292Nucleotide sequence and intracellular location of the product of the fosfomycin resistance gene from transposon Tn2921.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/1963292PubMed
1428694609Role of Biofilm in Cerebrospinal Fluid Shunt Infections: A Study at Tertiary Neurocare Center from South India.J Neurosci Rural Pract2017https://conductscience.org/library/papers/28694609PubMed
159023661In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii.J Antimicrob Chemother1996https://conductscience.org/library/papers/9023661PubMed
1627584587The management of multidrug-resistant Enterobacteriaceae.Curr Opin Infect Dis2016https://conductscience.org/library/papers/27584587PubMed
1728442293Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.Lancet Infect Dis2017https://conductscience.org/library/papers/28442293PubMed
186348661[Diffusion of fosfomycin into bone tissue in man].Pathol Biol (Paris)1983https://conductscience.org/library/papers/6348661PubMed
1924107389Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin.J Antimicrob Chemother2014https://conductscience.org/library/papers/24107389PubMed
2027401568Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27401568PubMed

See all 120 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42847693Biapenem-fosfomycin shows enhanced in vitro activity compared with meropenem-fosfomycin against NDM-producing Enterobacterales.Microbiol Spectr2026https://conductscience.org/library/papers/42847693PubMed
42505654The Pharmacology of Bacterial Persistence: From Antibiotic Tolerance to Antimicrobial Resistance.Antibiotics (Basel)2026https://conductscience.org/library/papers/42505654PubMed
42273017Emergence of Fosfomycin Resistance Among ESBL-Producing Escherichia coli in Abadan, Southwestern Iran.Health Sci Rep2026https://conductscience.org/library/papers/42273017PubMed
41627487Therapeutic milestones against multidrug resistant Acinetobacter baumannii: from legacy antibiotics to Zosurabalpin.Arch Microbiol2026https://conductscience.org/library/papers/41627487PubMed
40410452Fosfomycin for the treatment of patients with bacterial prostatitis: a systematic review.Eur J Clin Microbiol Infect Dis2025https://conductscience.org/library/papers/40410452PubMed
39948320Mechanisms, therapeutic strategies, and emerging therapeutic alternatives for carbapenem resistance in Gram-negative bacteria.Arch Microbiol2025https://conductscience.org/library/papers/39948320PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39282196

GET https://conductscience.org/api/papers/v1/39282196/references?page=2